Search - tctmd.com

Displaying 21 - 30 of 30

Sort: Relevancy | Date

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Presentation TVT 2022

Transcatheter aortic valve implantation with zero contrast technique in chronic kidney disease population - Evolut - zero CKD Pilot study

Presenter: Pedro Nicz

June 08, 2022

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

News Conference News EuroPCR 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Yael L. Maxwell

May 27, 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

April 05, 2022

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

News Daily News

‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible

Michael O'Riordan

March 21, 2022

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

March 14, 2022

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

News Daily News

Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality

Michael O'Riordan

March 10, 2022

Good Results For TAVI in Bicuspid Valves, But Questions Persist

News Daily News

Good Results For TAVI in Bicuspid Valves, but Questions Persist

Michael O'Riordan

March 08, 2022

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

News Daily News

Ross Procedure Again Surpasses Bioprosthetic AVR: Toronto Experience

March 08, 2022

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

News Daily News

Surgery for IE After TAVI No Better Than Antibiotics in High-Risk Patients

Michael O'Riordan

February 25, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.